Colonial Trust’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.4K Buy
215
+93
+76% +$1.62K ﹤0.01% 949
2026
Q1
$2.39K Sell
122
-6
-5% -$130 ﹤0.01% 1002
2025
Q4
$2.88K Buy
+128
New +$2.31K ﹤0.01% 962

Other funds holding TNDM

Colonial Trust's TNDM Position: Q2 2026 in Review

Colonial Trust increased its Tandem Diabetes Care (TNDM) stake by 76% in Q2 2026, buying an estimated $1.62K and bringing the position to 215 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #949.

Colonial Trust first reported a position in TNDM in Q4 2025 and has held it in 3 quarters since. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Colonial Trust held 215 shares of Tandem Diabetes Care worth $3.4K as of Q2 2026.
  • Colonial Trust bought 93 Tandem Diabetes Care shares in Q2 2026, an estimated $1.62K.
  • Tandem Diabetes Care made up ﹤0.01% of Colonial Trust's portfolio in Q2 2026, its #949 holding.
  • Colonial Trust first reported a position in Tandem Diabetes Care in Q4 2025 and has held it in 3 quarters since.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.